199 related articles for article (PubMed ID: 38491013)
1. Translation efficiency driven by CNOT3 subunit of the CCR4-NOT complex promotes leukemogenesis.
Ghashghaei M; Liu Y; Ettles J; Bombaci G; Ramkumar N; Liu Z; Escano L; Miko SS; Kim Y; Waldron JA; Do K; MacPherson K; Yuen KA; Taibi T; Yue M; Arsalan A; Jin Z; Edin G; Karsan A; Morin GB; Kuchenbauer F; Perna F; Bushell M; Vu LP
Nat Commun; 2024 Mar; 15(1):2340. PubMed ID: 38491013
[TBL] [Abstract][Full Text] [Related]
2. CNOT3 targets negative cell cycle regulators in non-small cell lung cancer development.
Shirai YT; Mizutani A; Nishijima S; Horie M; Kikuguchi C; Elisseeva O; Yamamoto T
Oncogene; 2019 Apr; 38(14):2580-2594. PubMed ID: 30531840
[TBL] [Abstract][Full Text] [Related]
3. CNOT3 contributes to cisplatin resistance in lung cancer through inhibiting RIPK3 expression.
Jing L; Zhai ME; Cui J; Fan XY; Cheng YY; Jiang JL; Chen ZN
Apoptosis; 2019 Aug; 24(7-8):673-685. PubMed ID: 31177396
[TBL] [Abstract][Full Text] [Related]
4. Involvement of CNOT3 in mitotic progression through inhibition of MAD1 expression.
Takahashi A; Kikuguchi C; Morita M; Shimodaira T; Tokai-Nishizumi N; Yokoyama K; Ohsugi M; Suzuki T; Yamamoto T
Biochem Biophys Res Commun; 2012 Mar; 419(2):268-73. PubMed ID: 22342980
[TBL] [Abstract][Full Text] [Related]
5. Interaction of CCR4-NOT with EBF1 regulates gene-specific transcription and mRNA stability in B lymphopoiesis.
Yang CY; Ramamoorthy S; Boller S; Rosenbaum M; Rodriguez Gil A; Mittler G; Imai Y; Kuba K; Grosschedl R
Genes Dev; 2016 Oct; 30(20):2310-2324. PubMed ID: 27807034
[TBL] [Abstract][Full Text] [Related]
6. Targeting the up-regulated CNOT3 reverses therapeutic resistance and metastatic progression of EGFR-mutant non-small cell lung cancer.
Jing L; Zhai ME; Qian MR; Li YM; Han MW; Wang K; Huang W; Nan G; Jiang JL
Cell Death Discov; 2023 Nov; 9(1):406. PubMed ID: 37919290
[TBL] [Abstract][Full Text] [Related]
7. CNOT3-Dependent mRNA Deadenylation Safeguards the Pluripotent State.
Zheng X; Yang P; Lackford B; Bennett BD; Wang L; Li H; Wang Y; Miao Y; Foley JF; Fargo DC; Jin Y; Williams CJ; Jothi R; Hu G
Stem Cell Reports; 2016 Nov; 7(5):897-910. PubMed ID: 27746116
[TBL] [Abstract][Full Text] [Related]
8. Specific recognition and ubiquitination of translating ribosomes by mammalian CCR4-NOT.
Absmeier E; Chandrasekaran V; O'Reilly FJ; Stowell JAW; Rappsilber J; Passmore LA
Nat Struct Mol Biol; 2023 Sep; 30(9):1314-1322. PubMed ID: 37653243
[TBL] [Abstract][Full Text] [Related]
9. Stability of mRNA influences osteoporotic bone mass via CNOT3.
Watanabe C; Morita M; Hayata T; Nakamoto T; Kikuguchi C; Li X; Kobayashi Y; Takahashi N; Notomi T; Moriyama K; Yamamoto T; Ezura Y; Noda M
Proc Natl Acad Sci U S A; 2014 Feb; 111(7):2692-7. PubMed ID: 24550297
[TBL] [Abstract][Full Text] [Related]
10. Mutations in the
Collart MA; Kassem S; Villanyi Z
Front Genet; 2017; 8():61. PubMed ID: 28588606
[TBL] [Abstract][Full Text] [Related]
11. MiRNA-124 regulates the sensitivity of renal cancer cells to cisplatin-induced necroptosis by targeting the CAPN4-CNOT3 axis.
Mao Q; Zhuang Q; Shen J; Chen Z; Xue D; Ding T; He X
Transl Androl Urol; 2021 Sep; 10(9):3669-3683. PubMed ID: 34733662
[TBL] [Abstract][Full Text] [Related]
12. CNOT3 is a modifier of PRPF31 mutations in retinitis pigmentosa with incomplete penetrance.
Venturini G; Rose AM; Shah AZ; Bhattacharya SS; Rivolta C
PLoS Genet; 2012; 8(11):e1003040. PubMed ID: 23144630
[TBL] [Abstract][Full Text] [Related]
13. A minicircuitry of microRNA-9-1 and RUNX1-RUNX1T1 contributes to leukemogenesis in t(8;21) acute myeloid leukemia.
Fu L; Shi J; Liu A; Zhou L; Jiang M; Fu H; Xu K; Li D; Deng A; Zhang Q; Pang Y; Guo Y; Hu K; Zhou J; Wang Y; Huang W; Jing Y; Dou L; Wang L; Xu K; Ke X; Nervi C; Li Y; Yu L
Int J Cancer; 2017 Feb; 140(3):653-661. PubMed ID: 27770540
[TBL] [Abstract][Full Text] [Related]
14. RNA Demethylase ALKBH5 Selectively Promotes Tumorigenesis and Cancer Stem Cell Self-Renewal in Acute Myeloid Leukemia.
Shen C; Sheng Y; Zhu AC; Robinson S; Jiang X; Dong L; Chen H; Su R; Yin Z; Li W; Deng X; Chen Y; Hu YC; Weng H; Huang H; Prince E; Cogle CR; Sun M; Zhang B; Chen CW; Marcucci G; He C; Qian Z; Chen J
Cell Stem Cell; 2020 Jul; 27(1):64-80.e9. PubMed ID: 32402250
[TBL] [Abstract][Full Text] [Related]
15. Obesity resistance and increased hepatic expression of catabolism-related mRNAs in Cnot3+/- mice.
Morita M; Oike Y; Nagashima T; Kadomatsu T; Tabata M; Suzuki T; Nakamura T; Yoshida N; Okada M; Yamamoto T
EMBO J; 2011 Sep; 30(22):4678-91. PubMed ID: 21897366
[TBL] [Abstract][Full Text] [Related]
16. CNOT3 suppression promotes necroptosis by stabilizing mRNAs for cell death-inducing proteins.
Suzuki T; Kikuguchi C; Sharma S; Sasaki T; Tokumasu M; Adachi S; Natsume T; Kanegae Y; Yamamoto T
Sci Rep; 2015 Oct; 5():14779. PubMed ID: 26437789
[TBL] [Abstract][Full Text] [Related]
17.
Chen Q; Malki S; Xu X; Bennett B; Lackford BL; Kirsanov O; Geyer CB; Hu G
bioRxiv; 2023 Oct; ():. PubMed ID: 37873304
[TBL] [Abstract][Full Text] [Related]
18. HOXBLINC long non-coding RNA activation promotes leukemogenesis in NPM1-mutant acute myeloid leukemia.
Zhu G; Luo H; Feng Y; Guryanova OA; Xu J; Chen S; Lai Q; Sharma A; Xu B; Zhao Z; Feng R; Ni H; Claxton D; Guo Y; Mesa RA; Qiu Y; Yang FC; Li W; Nimer SD; Huang S; Xu M
Nat Commun; 2021 Mar; 12(1):1956. PubMed ID: 33782403
[TBL] [Abstract][Full Text] [Related]
19. Cnot3 enhances human embryonic cardiomyocyte proliferation by promoting cell cycle inhibitor mRNA degradation.
Zhou B; Liu J; Ren Z; Yao F; Ma J; Song J; Bennett B; Zhen Y; Wang L; Hu G; Hu S
Sci Rep; 2017 May; 7(1):1500. PubMed ID: 28473716
[TBL] [Abstract][Full Text] [Related]
20. Clinical features of CNOT3-associated neurodevelopmental disorder in three Chinese patients.
Zhao P; Meng Q; Wan C; Lei T; Zhang L; Zhang X; Tan L; Zhu H; He X
Neurogenetics; 2023 Apr; 24(2):129-136. PubMed ID: 36802310
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
